LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

LLY

1,066.57

-0.02%↓

JNJ

230.23

-1.85%↓

ABBV

212.63

-1.61%↓

UNH

377.52

-2.74%↓

AZN

187.14

-0.06%↓

Search

Cellectar Biosciences Inc

Geschlossen

3 -6.83

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3

Max

3.2800000000000002

Schlüsselkennzahlen

By Trading Economics

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+222.81% upside

Cellectar Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

26. Mai 2026, 16:52 UTC

Wichtige Nachrichtenereignisse

NYMEX Overview: Brent Crude Futures Up; Iran Warns of Retaliation After US Strike -- OPIS

26. Mai 2026, 23:57 UTC

Ergebnisse

Sociedad Quimica 1Q Rev $1.76B >SQM

26. Mai 2026, 23:57 UTC

Ergebnisse

Sociedad Quimica 1Q EPS $1.28 >SQM

26. Mai 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

26. Mai 2026, 21:54 UTC

Ergebnisse

Webco Industries 3Q EPS $11.61 >WEBC

26. Mai 2026, 21:54 UTC

Ergebnisse

Webco Industries 3Q Sales $179.6M >WEBC

26. Mai 2026, 21:48 UTC

Market Talk

GE Aerospace's Repair Boom Should Last for Years -- Market Talk

26. Mai 2026, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

26. Mai 2026, 20:58 UTC

Akquisitionen, Fusionen, Übernahmen

Uber's $11.6 Billion Bid for DoorDash Rival Is About Future Proofing It From Robots -- Barrons.com

26. Mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26. Mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

26. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

26. Mai 2026, 19:22 UTC

Market Talk

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

26. Mai 2026, 19:17 UTC

Market Talk

Oil Recovers Some Losses on U.S.-Iran Skirmishes -- Market Talk

26. Mai 2026, 18:56 UTC

Market Talk

U.S. Natural Gas Futures Slip in Rangebound Trading -- Market Talk

26. Mai 2026, 18:03 UTC

Market Talk

AutoCanada Faces Soft Demand, Slow Normalization -- Market Talk

26. Mai 2026, 17:42 UTC

Market Talk

Grains Await Fresh Trading Catalyst -- Market Talk

26. Mai 2026, 17:33 UTC

Market Talk

Salesforce, Snowflake Could Dispel Software Bear Thesis -- Market Talk

26. Mai 2026, 17:21 UTC

Market Talk

Canada Faces a Labor Market Squeeze -- Market Talk

26. Mai 2026, 16:52 UTC

Market Talk

Bonds to Fund Infrastructure for Data Centers Could Be Risky -- Market Talk

26. Mai 2026, 16:43 UTC

Market Talk

Spotify's Latest Audio Play: Magazine Articles -- Market Talk

26. Mai 2026, 16:24 UTC

Market Talk

Dollarama's LATAM Slowdown, Australia Costs Seen as Transient -- Market Talk

26. Mai 2026, 16:21 UTC

Market Talk

Oil Extends Gains As Strikes Add Tension to U.S.-Iran Talks -- Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

26. Mai 2026, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Auto & Transport Roundup: Market Talk

26. Mai 2026, 16:16 UTC

Market Talk

Alberta Separation Threat Poses Headwind for Canada Dollar -- Market Talk

26. Mai 2026, 16:01 UTC

Market Talk

Bitcoin Lower as Stress Builds for Holders -- Market Talk

26. Mai 2026, 15:21 UTC

Market Talk

Hyperliquid Pushes Up to New All-Time High -- Market Talk

Peer-Vergleich

Kursveränderung

Cellectar Biosciences Inc Prognose

Kursziel

By TipRanks

222.81% Vorteil

12-Monats-Prognose

Durchschnitt 10.33 USD  222.81%

Hoch 11 USD

Tief 10 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cellectar Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat